Teva Pharma (TEVA) Misses Q3 EPS by 1c, Updates FY Guidance
Tweet Send to a Friend
Teva Pharma (NYSE: TEVA) reported Q3 EPS of $0.58, $0.01 worse than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
